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Sunday, February 16, 2014 69adifferences in DNA structure within tumor initiation and tumor promotion sites.
Right-handed double-stranded (ds-) B-DNA is the conventional structure of
DNA that results in the majority of DNA. As part of our past work we examined
the epidermis of normal human skin for the presence of ds-B-DNA as it un-
dergoes destruction due to normal cell death processes [i.e., apoptosis and ter-
minal differentiation (denucleation)]. Our research team has examined the
distribution and intensity of anti-B-DNA antibody binding in human mela-
noma; formalin-fixed paraffin-embedded tissue sections (1 micron). We also
employed a variety of different anti-melanoma antibody probes [e.g.,
(HMB45) (ab787)]. Using enhanced histotechnological processing procedures
we were able to better preserve the melanoma tissue-bound B-DNA (i.e., intact,
unaltered and non-denatured nucleic acids). Superior preservation of tissue-
bound components resulted in improved characterization of the immunostain-
ing data (1). We characterized the lateral and vertical margins of the epidermal
tumor growth to see if any changes were occurring in the non-cancerous areas
of the epidermis next to the tumor sites. We found that B-DNA is located in all
cells, and that the binding intensity [mean optical density] of immunohisto-
chemistry is similar in all regions of the cancerous growth. Being able to locate
hyperactive regions of B-DNA in the tumor growth will allow for new drug
target sites. disease. 1. Gagna C.E., et al., (2007) Novel DNA Staining Method
and Processing Technique for the Quantification of Undamaged Double-
Stranded DNA in Epidermal Tissue Sections by PicoGreen Probe Staining
and Microspectrophotometry. Journal of Histochemistry and Cytochemistry.
55: 999-1014. Supported by a NYIT-ISRC grant.
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Stage III melanoma refers to tissue tumors that have spread to regional lymph
nodes, or have developed in transit metastasis (regional). With treatment this
pathology is considered intermediate to high risk for recurrence locally or for
distant metastasis. Consequently, new approaches towards treating melanoma
need to be developed. Right-handed double-stranded (ds-) B-DNA is the
most common structure that makes up the majority of DNA. Tissue samples
were preserved in several different tissue fixatives (molecular grade), in order
to better characterize DNA and DNA-protein complex interactions (10%
formalin, 10% neutral buffered formalin, Clarke’s solution, Carnoy’s, solution,
and zinc formalin fixative). Previously, we have characterized the epidermis of
human skin for the presence of ds-B-DNA as it undergoes cell death [i.e.,
apoptosis and terminal differentiation]. Our data reveals the distribution and in-
tensity of anti-B-DNA, anti-single-stranded DNA, anti-Z-RNA antibody bind-
ing, and a variety of different anti-melanoma antibody, in human melanoma
(IIIA, IIIB, and IIIC). We carefully observed the differences in DNA structure
within the papillary dermis. The intensity of immunohistochemical staining is
different within certain regions of the cancerous growth, namely, less immuno-
histochemical staining in the lateral regional and much more in the vertical
areas. Less ss-DNAwas seen in the vertical areas (reticular dermis). Employing
novel histotechnological processing procedures we were able to better preserve
the tissue-bound ds-B-DNA as intact, unaltered and non-denatured molecules
(1). This has resulted in improvements involving laser capture dissection tech-
niques for the isolation of genetic materials. 1. Gagna CE, et al., (2007) Novel
DNA Staining Method and Processing Technique for the Quantification of Un-
damaged Double-Stranded DNA in Epidermal Tissue Sections by PicoGreen
Probe Staining and Microspectrophotometry. Journal of Histochemistry and
Cytochemistry. 55: 999-1014. This research project was supported in part by
a 2011 ISRC grant.
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Medicinal treatments for this pathology are limited and therefore new
approaches need to be taken, namely, new classes of drugs and/or biologicals.
Tissues were processed in formalin-fixed and non-formalin-fixed paraffin-
embedded tissue sections. Proper fixation of melanoma tissue samples is
critical for the correct preservation of tissue morphology, and especially
tissue-bound nucleic acids. Improper fixation will lead to regions of single-
stranded (ss-) DNA that can interfere with the correct characterization of thetissue-bound components. Our group has developed a histotechnological proce-
dure to preserve undamaged nucleic acids (1). Right-handed double-stranded
(ds-) B-DNA is the conventional structure of DNA. In the past we have exam-
ined the epidermis of normal human skin for the presence of ds-B-DNA, ds-Z-
DNA as it undergoes destruction due to the normal process of cell death
[apoptosis and terminal differentiation (denucleation)]. Our research team
has examined the distribution and intensity of anti-B-DNA antibody and
anti-melanoma antibody binding in human melanoma (Ia and I B). Our results
show that B-DNA is located in all cells of the melanoma tissue; however, the
intensity of immunohistochemical staining is different within certain regions of
the cancerous growth (an increased amount of ds-DNA content the vertical
growth phase zone: papillary dermis). Using enhanced histotechnological pro-
cessing procedures we were able to better preserve the tissue-bound ds-B-DNA,
which was not damaged from tissue processing (i.e., ds-DNA converting to ss-
DNA). This resulted in intact ds-B-DNA. Being able to locate intact ds-B-DNA
in the cells of cancer will allow for the identification of specific target sites. 1.
Gagna C.E., et al., (2007) Novel DNA Staining Method and Processing Tech-
nique for the Quantification of Undamaged Double-Stranded DNA in
Epidermal Tissue Sections by PicoGreen Probe Staining and Microspectropho-
tometry. Journal of Histochemistry and Cytochemistry. 55: 999-1014. Sup-
ported by a 2011 ISRC grant.
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Stage II melanoma is a localized tissue tumor. Proper fixation of melanoma
tissue samples is extremely important for the accurate preservation of tissue
morphology, and mainly nucleic acids. Incorrect histotechnological fixation
will lead to regions of denatured single-stranded DNA that can interfere
with the correct characterization of the nucleic acid tissue-bound components.
We have developed a procedure to preserve intact nucleic acids (1). Right-
handed double-stranded (ds-) B-DNA is the conventional structure of DNA.
Our team has examined the epidermis of normal human skin for the presence
of ds-B-DNA as it undergoes cell death [apoptosis and terminal differentia-
tion]. Our group has now examined the distribution and intensity of anti-B-
DNA antibody, anti-melanoma antibody, and anti-single-stranded (ss-)
DNA binding in Stage II human melanoma. Our results show that B-DNA
is located in all cells of the melanoma tissue; however, the intensity of immu-
nohistochemical staining is different within certain regions of the cancerous
growth. Less immunohistochemical staining was found in the lateral regional
and more in the vertical areas (i.e., papillary dermis). Using enhanced histo-
technological processing procedures we were able to better preserve the
tissue-bound ds-B-DNA. Consequently, the DNA was not damaged from tis-
sue processing, and did not result in denatured ss-DNA that would interfere
with the characterization of ds-B-DNA. We are also looking at differences
between the DNA of ulcerated and non-ulcerated melanomas. Being able
to differentiate between ds-B-DNA and ss-DNA in the cancer tissue will
allow for the identification of specific nucleic acid target sites. 1. Gagna
C.E., et al., (2007) Novel DNA Staining Method and Processing Technique
for the Quantification of Undamaged Double-Stranded DNA in Epidermal
Tissue Sections by PicoGreen Probe Staining and Microspectrophotometry.
Journal of Histochemistry and Cytochemistry. 55: 999-1014. Supported by
an ISRC grant.
Protein-Nucleic Acid Interactions I
374-Pos Board B129
The Mechanism of Nucleosome Spacing by a Dimeric Chromatin Remod-
eling Enzyme
John D. Leonard1, Jean-Paul Armache1, Nariman Naber1, Shenping Wu1,
Edward Pate2, Roger Cooke1, Yifan Cheng1, Geeta J. Narlikar1.
1Biochemistry and Biophysics, University of California, San Francisco, San
Francisco, CA, USA, 2Chemical Engineering and Bioengineering,
Washington State University, Pullman, WA, USA.
Transcriptional regulation and cellular differentiation involve changes in the
structure, composition and post-translational modification state of chromatin,
the material that packages the eukaryotic genome. Changes to chromatin struc-
ture require the action of chromatin remodeling enzymes, protein complexes
that use the energy of ATP hydrolysis to move, disassemble or deposit nucle-
osomes. Despite their central importance to chromatin biology, the mechanism
by which chromatin remodelers break histone-DNA contacts and reposition
